A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH
Clinical trial NCT00296465 · COMPLETED
Trial details
- NCT number
- NCT00296465
- Sponsor
- Ferring Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-02-01
- Primary completion
- 2005-11-01
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.